C3 Glomerulopathy (C3G)
5 clinical trials · Condition
◉ Watch C3 Glomerulopathy (C3G)
| Record | Firm | Date |
|---|---|---|
| Controlled Trial Evaluating Avacopan in C3 Glomerulopathy (NCT03301467) | Amgen | 2017-09-29 |
| Managed Access Programs for LNP023, Iptacopan (NCT05222412) | Novartis Pharmaceuticals |
Track C3 Glomerulopathy (C3G) automatically
Every clearance here is in the API, with alerts when new ones post.